genome mapping
Written by early OGM adopters, the framework describes best practices for the technology's clinical implementation for hematological malignancies.
Bionano Genomics Acquires Diagnostic Services Provider Lineagen for $9.6M
The deal consists of cash, Bionano common stock, and assumption of liabilities. Bionano has also paid off $1.1 million loaned to Lineagen under the CARES act.
Bionano Genomics Expecting Clinical Validation Studies to Drive Platform Adoption
The firm is hoping that researcher-generated data will soon be published in peer-reviewed papers, while it weathers the COVID-19 pandemic.
Bionano Genomics to Publicly Offer Securities, Amends Loan Agreement
The genome mapping firm had fallen out of compliance with respect to its loan agreement with Innovatus and will prepay $5 million toward the loan principal.
Bionano Genomics Commences Public Stock Offering
The firm is offering approximately 13.8 million shares and the same number of warrants to purchase shares, which will be sold together.